USD10
ARTV Shares
About Artiva BiotherapeuticsArtiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
USD10
ARTV Shares
About Artiva BiotherapeuticsArtiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM GMT+0
MARKET CAP
$136.19M
OPEN PRICE
$5.37
LOW (1Y)
$1.47
HIGH (1Y)
$7.75
LOW (24H)
$5.37
HIGH (24H)
$5.66
VOLUME (24H)
$18.22K
79.38%
Price history
Time | Price | Change |
|---|---|---|
Today | $5.37 | |
1 Day | $5.31 | |
1 Week | $5.83 | |
1 Month | $4.96 | |
1 Year | $3.64 |
A new era of Coinbase has begun
The future of money is here. Be one of the first to get access and try new features the moment they’re available.
Create an account now